CLINICAL POTENTIAL OF CARIPRAZINE IN THE TREATMENT OF ACUTE MANIA [PDF]
Cariprazine (RGH-188, trans-4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexyl-amine hydrochloride), is a novel antipsychotic with dopamine D2 and D3 receptors antagonist–partial agonist properties. Cariprazine has also
Esat Timuçin Oral +2 more
core +1 more source
Stability indicating RP-HPLC method for estimation of cariprazine hydrochloride in human plasma
Objective: The objective of the study is to create and validate the easy, dependable, accurate, sensitive, and selective RP-HPLC method for estimating Cariprazine HCl in human plasma.
Mohini Shelke +4 more
doaj +1 more source
Exploring cariprazine as a treatment option for varied depression symptom clusters
Major depressive disorder (MDD) is among the most prevalent psychiatric conditions and a leading cause of disability worldwide. MDD presents a diverse range of symptoms that significantly impact personal, societal, and economic dimensions.
Bojana Pejušković +5 more
doaj +1 more source
Cariprazine is one of the newer generation antipsychotics with dopamine receptor partial agonist activity which has been approved for management of schizophrenia and bipolar affective disorder.
Devendra Singh Basera +3 more
doaj +1 more source
Folyadékfázisú, heterogén katalitikus reakciók alkalmazása szerves kémiai szintézisekben [PDF]
Hegedűs, László, Hell, Zoltán
core +1 more source
A hasüregi adhéziók kialakulását befolyásoló tényezők, következményeik és a prevenció lehetőségei [PDF]
Szabó, Györgyi
core +1 more source
Cariprazine: An Antipsychotic Medication with High Therapeutic Potential [PDF]
Introduction and purposeCariprazine is an atypical antipsychotic drug approved for the treatment of schizophrenia, as well as manic and mixed episodes associated with bipolar disorder.
Babkiewicz-Jahn, Kamila +9 more
core +1 more source
Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis [PDF]
\ua9 2024 The AuthorsBackground: Cariprazine has emerged as a promising augmenting treatment agent for unipolar depression and as a monotherapy option for bipolar depression.
Fernandes LA +7 more
core
Effects of cariprazine on cholesterol, glucose, and weight in patients with schizophrenia: a systematic review and meta-analysis. [PDF]
Berardelli I +6 more
europepmc +1 more source
High-density EEG study in patients with schizophrenia treated with cariprazine. [PDF]
Czobor P +3 more
europepmc +1 more source

